The schizophrenia-related protein dysbindin-1a is degraded and facilitates NF-Kappa B activity in the nucleus

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Fu, Cheng ^a   Chen, Dong ^b   Chen, Ruijie ^c   Hu, Qingsong ^b   Wang, Guanghui ^a,b   Lim, Kah Leong ^d  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b SOOCHOW UNIVERSITY   (China)

^c THE SECOND AFFILIATED HOSPITAL AND YUYING CHILDREN S HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

DYSBINDIN; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA; DTNBP1 PROTEIN, HUMAN; DYSTROPHIN ASSOCIATED PROTEIN; PROTEASOME; TUMOR NECROSIS FACTOR; UBIQUITIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; DTNBP1 GENE; GENE FUNCTION; GENE IDENTIFICATION; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NERVE FIBER GROWTH; NEUROTRANSMITTER RELEASE; NONHUMAN; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; SCHIZOPHRENIA; UPREGULATION; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; METABOLISM;

CELL NUCLEUS; DYSTROPHIN-ASSOCIATED PROTEINS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEK293 CELLS; HUMANS; MATRIX METALLOPROTEINASE 9; NF-KAPPA B; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEOLYSIS; SCHIZOPHRENIA; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; UBIQUITIN;

EID: 84940510235     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0132639     Document Type: Article

References (43)

1. Burdick KE, Goldberg TE, Funke B, Bates JA, Lencz T, Kucherlapati R, et al. DTNBP1 genotype influences cognitive decline in schizophrenia. Schizophr Res. 2007; 89(1-3):169-72. Epub 2006/11/01. S0920-9964(06)00396-3. PMID: 17074466.
2. Burdick KE, Lencz T, Funke B, Finn CT, Szeszko PR, Kane JM, et al. Genetic variation in DTNBP1 influences general cognitive ability. Hum Mol Genet. 2006; 15(10):1563-8. Epub 2006/01/18. ddi481. PMID: 16415041.
3. Weickert CS, Straub RE, McClintock BW, Matsumoto M, Hashimoto R, Hyde TM, et al. Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain. Arch Gen Psychiatry. 2004; 61(6):544-55. Epub 2004/06/09. doi: 10.1001/archpsyc.61.6.544 PMID: 15184234.
4. Talbot K, Eidem WL, Tinsley CL, Benson MA, Thompson EW, Smith RJ, et al. Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. J Clin Invest. 2004; 113(9):1353-63. Epub 2004/05/05. doi: 10.1172/JCI20425 PMID: 15124027.
5. Takao K, Toyama K, Nakanishi K, Hattori S, Takamura H, Takeda M, et al. Impaired long-term memory retention and working memory in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia. Mol Brain. 2008; 1:11. Epub 2008/10/24.1756-6606-1-11. PMID: 18945333. doi: 10.1186/1756-6606-1-11
6. Feng YQ, Zhou ZY, He X, Wang H, Guo XL, Hao CJ, et al. Dysbindin deficiency in sandy mice causes reduction of snapin and displays behaviors related to schizophrenia. Schizophr Res. 2008; 106(2-3):218-28. Epub 2008/09/09. S0920-9964(08)00336-8. PMID: 18774265. doi: 10.1016/j.schres.2008.07.018
7. Hattori S, Murotani T, Matsuzaki S, Ishizuka T, Kumamoto N, Takeda M, et al. Behavioral abnormalities and dopamine reductions in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia. Biochem Biophys Res Commun. 2008; 373(2):298-302. Epub 2008/06/17. S0006-291X(08) 01162-5. PMID: 18555792. doi: 10.1016/j.bbrc.2008.06.016
8. Numakawa T, Yagasaki Y, Ishimoto T, Okada T, Suzuki T, Iwata N, et al. Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia. Hum Mol Genet. 2004; 13(21):2699-708. Epub 2004/09/04. doi: 10.1093/hmg/ddh280 PMID: 15345706.
9. Chen XW, Feng YQ, Hao CJ, Guo XL, He X, Zhou ZY, et al. DTNBP1, a schizophrenia susceptibility gene, affects kinetics of transmitter release. J Cell Biol. 2008; 181(5):791-801. Epub 2008/05/28. jcb.200711021. PMID: 18504299. doi: 10.1083/jcb.200711021
10. Iizuka Y, Sei Y, Weinberger DR, Straub RE. Evidence that the BLOC-1 protein dysbindin modulates dopamine D2 receptor internalization and signaling but not D1 internalization. J Neurosci. 2007; 27 (45):12390-5. Epub 2007/11/09. 27/45/12390. PMID: 17989303.
11. Tang TT, Yang F, Chen BS, Lu Y, Ji Y, Roche KW, et al. Dysbindin regulates hippocampal LTP by controlling NMDA receptor surface expression. Proc Natl Acad Sci USA. 2009; 106(50):21395-400. Epub 2009/12/04. 0910499106. PMID: 19955431. doi: 10.1073/pnas.0910499106
12. Ito H, Morishita R, Shinoda T, Iwamoto I, Sudo K, Okamoto K, et al. Dysbindin-1, WAVE2and Abi-1 form a complex that regulates dendritic spine formation. Mol Psychiatry. 2010; 15(10):976-86. Epub 2010/06/10.mp201069. PMID: 20531346. doi: 10.1038/mp.2010.69
13. Jia JM, Hu Z, Nordman J, Li Z. The schizophrenia susceptibility gene dysbindin regulates dendritic spine dynamics. J Neurosci. 2014; 34(41):13725-36. doi: 10.1523/JNEUROSCI.0184-14.2014 PMID: 25297099.
14. Kubota K, Kumamoto N, Matsuzaki S, Hashimoto R, Hattori T, Okuda H, et al. Dysbindin engages in c-Jun N-terminal kinase activity and cytoskeletal organization. Biochem Biophys Res Commun. 2009; 379(2):191-5. Epub 2008/12/20. S0006-291X(08)02394-2. PMID: 19094965. doi: 10.1016/j.bbrc.2008.12.017
15. Ghiani CA, Starcevic M, Rodriguez-Fernandez IA, Nazarian R, Cheli VT, Chan LN, et al. The dysbindin-containing complex (BLOC-1) in brain: developmental regulation, interaction with SNARE proteins and role in neurite outgrowth. Mol Psychiatry. 2010; 15(2):115, 204-15. Epub 2009/06/24. mp200958. PMID: 19546860. doi: 10.1038/mp.2009.58
16. Ma X, Fei E, Fu C, Ren H, Wang G. Dysbindin-1, a schizophrenia-related protein, facilitates neurite outgrowth by promoting the transcriptional activity of p53. Mol Psychiatry. 2011; 16(11):1105-16. Epub 2011/04/20. mp201143. PMID: 21502952. doi: 10.1038/mp.2011.43
17. Oyama S, Yamakawa H, Sasagawa N, Hosoi Y, Futai E, Ishiura S. Dysbindin-1, a schizophrenia-related protein, functionally interacts with the DNA-dependent protein kinase complex in an isoform-dependent manner. PLoSOne. 2009; 4(1):e4199. Epub 2009/01/15. doi: 10.1371/journal.pone.0004199 PMID: 19142223.
18. Okuda H, Kuwahara R, Matsuzaki S, Miyata S, Kumamoto N, Hattori T, et al. Dysbindin regulates the transcriptional level of myristoylated alanine-rich protein kinase C substrate via the interaction with NF-YB in mice brain. PLoSOne. 2010; 5(1):e8773. Epub 2010/01/26. doi: 10.1371/journal.pone.0008773 PMID: 20098743.
19. Fei E, Ma X, Zhu C, Xue T, Yan J, Xu Y, et al. Nucleocytoplasmic shuttling of dysbindin-1, a schizophrenia-related protein, regulates synapsin I expression. J Biol Chem. 2010; 285(49):38630-40. Epub 2010/10/06. M110.107912. PMID: 20921223. doi: 10.1074/jbc.M110.107912
20. Vawter MP, Thatcher L, Usen N, Hyde TM, Kleinman JE, Freed WJ. Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia. Mol Psychiatry. 2002; 7(6):571-8. doi: 10.1038/sj.mp.4001158 PMID: 12140780.
21. Gutierrez H, Hale VA, Dolcet X, Davies A. NF-kappaB signalling regulates the growth of neural processes in the developing PNS and CNS. Development. 2005; 132(7):1713-26. doi: 10.1242/dev.01702 PMID: 15743881.
22. Boersma MC, Dresselhaus EC, DeBiase LM, Mihalas AB, Bergles DE, Meffert MK. A requirement for nuclear factor-kappaB in developmental and plasticity-associated synaptogenesis. J Neurosci. 2011; 31(14):5414-25. doi: 10.1523/JNEUROSCI.2456-10.2011 PMID: 21471377.
23. Yeh SH, Lin CH, Lee CF, Gean PW. A requirement of nuclear factor-kappaB activation in fear-potentiated startle. J Biol Chem. 2002; 277(48):46720-9. doi: 10.1074/jbc.M206258200 PMID: 12351629.
24. Dash PK, Orsi SA, Moore AN. Sequestration of serum response factor in the hippocampus impairs long-term spatial memory. J Neurochem. 2005; 93(2):269-78. doi: 10.1111/j.1471-4159.2004.03016.x PMID: 15816850.
25. Denis-Donini S, Dellarole A, Crociara P, Francese MT, Bortolotto V, Quadrato G, et al. Impaired adult neurogenesis associated with short-term memory defects in NF-kappaB p50-deficient mice. J Neurosci. 2008; 28(15):3911-9. doi: 10.1523/JNEUROSCI.0148-08.2008 PMID: 18400889.
26. Ahn HJ, Hernandez CM, Levenson JM, Lubin FD, Liou HC, Sweatt JD. c-Rel, an NF-kappaB family transcription factor, is required for hippocampal long-term synaptic plasticity and memory formation. Learning & memory. 2008; 15(7):539-49. doi: 10.1101/lm.866408 PMID: 18626097.
27. Meffert MK, Chang JM, Wiltgen BJ, Fanselow MS, Baltimore D. NF-kappa B functions in synaptic signaling and behavior. Nat Neurosci. 2003; 6(10):1072-8. doi: 10.1038/nn1110 PMID: 12947408.
28. Roussos P, Katsel P, Davis KL, Giakoumaki SG, Lencz T, Malhotra AK, et al. Convergent findings for abnormalities of the NF-kappaB signaling pathway in schizophrenia. Neuropsychopharmacology. 2013; 38(3):533-9. doi: 10.1038/npp.2012.215 PMID: 23132271.
29. Locke M, Tinsley CL, Benson MA, Blake DJ.TRIM32 is an E3 ubiquitin ligasefordysbindin. Hum Mol Genet. 2009; 18(13):2344-58. Epub 2009/04/08. ddp167. PMID: 19349376. doi: 10.1093/hmg/ddp167
30. von Mikecz A. The nuclear ubiquitin-proteasome system. J Cell Sci. 2006; 119(Pt 10):1977-84. Epub 2006/05/12.119/10/1977. PMID: 16687735.
31. Radivojac P, Vacic V, Haynes C, Cocklin RR, Mohan A, Heyen JW, et al. Identification, analysis, and prediction of protein ubiquitination sites. Proteins. 2010; 78(2):365-80. doi: 10.1002/prot.22555 PMID: 19722269.
32. Ao Li XG, Jian Ren, Changjiang Jin, and Yu Xue. BDM-PUB: Computational Prediction of Protein Ubiquitination Sites with a Bayesian Discriminant Method. 2009.
33. Yap MY, Lo YL, Talbot K, Ong WY. Oxidative stress reduces levels of dysbindin-1Aviaits PEST domain. Neurochem Int. 2014; 79:65-9. doi: 10.1016/j.neuint.2014.10.001 PMID: 25445987.
34. Dziembowska M, Wlodarczyk J. MMP9: a novel function in synaptic plasticity. Int J Biochem Cell Biol. 2012; 44(5):709-13. doi: 10.1016/j.biocel.2012.01.023 PMID: 22326910.
35. Kaltschmidt B, Ndiaye D, Korte M, Pothion S, Arbibe L, Prullage M, et al. NF-kappaB regulates spatial memory formation and synaptic plasticity through protein kinase A/CREB signaling. Mol Cell Biol. 2006; 26(8):2936-46. doi: 10.1128/MCB.26.8.2936-2946.2006 PMID: 16581769.
36. Kudryashova E, Kudryashov D, Kramerova I, Spencer MJ. Trim32 is a ubiquitin ligase mutated in limb girdle muscular dystrophy type 2H that binds to skeletal muscle myosin and ubiquitinates actin. J Mol Biol. 2005; 354(2):413-24. doi: 10.1016/j.jmb.2005.09.068 PMID: 16243356.
37. Hough R, Pratt G, Rechsteiner M. Ubiquitin-lysozyme conjugates. Identification and characterization of an ATP-dependent protease from rabbit reticulocyte lysates. J Biol Chem. 1986; 261(5):2400-8. Epub 1986/02/15. PMID: 3003114.
38. Lingbeck JM, Trausch-Azar JS, Ciechanover A, Schwartz AL. Determinants of nuclear and cytoplasmic ubiquitin-mediated degradation of MyoD. J Biol Chem. 2003; 278(3):1817-23. doi: 10.1074/jbc.M208815200 PMID: 12397066.
39. Trausch-Azar J, Leone TC, Kelly DP, Schwartz AL. Ubiquitin proteasome-dependent degradation of the transcriptional coactivator PGC-1{alpha} via the N-terminal pathway. J Biol Chem. 2010; 285 (51):40192-200. doi: 10.1074/jbc.M110.131615 PMID: 20713359.
40. Alvarez-Castelao B, Losada F, Ahicart P, Castano JG. The N-terminal region of Nurr1 (a.a 1-31) is essential for its efficient degradation by the ubiquitin proteasome pathway. PLoSOne. 2013; 8(2): e55999. doi: 10.1371/journal.pone.0055999 PMID: 23409108.
41. Nagy V, Bozdagi O, Matynia A, Balcerzyk M, Okulski P, Dzwonek J, et al. Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory. J Neurosci. 2006; 26 (7):1923-34. doi: 10.1523/JNEUROSCI.4359-05.2006 PMID: 16481424.
42. Cox MM, Tucker AM, Tang J, Talbot K, Richer DC, Yeh L, et al. Neurobehavioral abnormalities in the dysbindin-1 mutant, sandy, on a C57BL/6J genetic background. Genes Brain Behav. 2009; 8(4):390-7. doi: 10.1111/j.1601-183X.2009.00477.x PMID: 19220483.
43. Karlsgodt KH, Robleto K, Trantham-Davidson H, Jairl C, Cannon TD, Lavin A, et al. Reduced dysbindin expression mediates N-methyl-D-aspartate receptor hypofunction and impaired working memory performance. Biol Psychiatry. 2011; 69(1):28-34. doi: 10.1016/j.biopsych.2010.09.012 PMID: 21035792.